financetom
Business
financetom
/
Business
/
Experts weigh in on surveillance measures post SEBI action on Franklin Templeton AMC
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Experts weigh in on surveillance measures post SEBI action on Franklin Templeton AMC
Jun 8, 2021 4:15 AM

Market regulator SEBI has come down heavily on Franklin Templeton Asset Management Company (FT-AMC), by transferring the fund management and advisory fee of the last two years to aggrieved investors. A move, which is certain to provide some solace to unitholders of the six shuttered schemes.

In an interview with CNBC-TV18, Ananth Narayan, Professor at SPJIMR, and Mahendra Jajoo, CIO-fixed income at Mirae Asset Investment Managers, discussed at length the move.

First up, Narayan said, “I am encouraged by the surveillance measures taken up by SEBI (with regard to the FT India case) and a lot of other steps that have been taken. Therefore, I am sure we will end up with an industry, which is in a stronger place than it was 18 months ago.”

Meanwhile, Jajoo said, “Categorising debt mutual funds (MFs) further as a step in the right direction. This is as clear as it can be in terms of classifying and offering a simple understanding of the features of the fund, including risk-return profile.”

For the entire discussion, watch the video.

(Edited by : Dipika Ghosh)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Telos Insider Bought Shares Worth $263,958, According to a Recent SEC Filing
Telos Insider Bought Shares Worth $263,958, According to a Recent SEC Filing
May 14, 2024
05:48 PM EDT, 05/14/2024 (MT Newswires) -- Fredrick Schaufeld, Director, on May 14, 2024, executed a purchase for 84,063 shares in Telos ( TLS ) for $263,958. Following the Form 4 filing with the SEC, Schaufeld has control over a total of 1,116,114 shares of the company, with 91,297 shares held directly and 1,024,817 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/320121/000032012124000027/xslF345X03/wk-form4_1715722855.xml Price:...
Davita Insider Sold Shares Worth $698,214, According to a Recent SEC Filing
Davita Insider Sold Shares Worth $698,214, According to a Recent SEC Filing
May 14, 2024
05:47 PM EDT, 05/14/2024 (MT Newswires) -- Barbara J Desoer, Director, on May 10, 2024, sold 5,030 shares in Davita ( DVA ) for $698,214. Following the Form 4 filing with the SEC, Desoer has control over a total of 10,954 shares of the company, with 10,954 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/927066/000092706624000095/xslF345X03/wk-form4_1715723029.xml Price: 136.40, Change: -0.61, Percent Change: -0.45 ...
Appfolio Insider Sold Shares Worth $531,600, According to a Recent SEC Filing
Appfolio Insider Sold Shares Worth $531,600, According to a Recent SEC Filing
May 14, 2024
05:47 PM EDT, 05/14/2024 (MT Newswires) -- Matthew S Mazza, Chief Legal Officer, on May 10, 2024, sold 2,131 shares in Appfolio ( APPF ) for $531,600. Following the Form 4 filing with the SEC, Mazza has control over a total of 43,680 shares of the company, with 43,680 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1433195/000143319524000067/xslF345X03/wk-form4_1715722915.xml ...
Lumos Pharma Plans Phase 3 Study of Growth Hormone Drug
Lumos Pharma Plans Phase 3 Study of Growth Hormone Drug
May 14, 2024
05:48 PM EDT, 05/14/2024 (MT Newswires) -- Lumos Pharma ( LUMO ) said Tuesday it completed end-of-phase 2 meeting with the US Food and Drug Administration with plans to move forward with a proposal of Phase 3 study of LUM-201, an oral growth hormone secretagogue. The proposed 12-month trial will enroll about 150 patients and the placebo-controlled portion of the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved